Matches in Wikidata for { <http://www.wikidata.org/entity/Q66072163> ?p ?o ?g. }
Showing items 1 to 59 of
59
with 100 items per page.
- Q66072163 description "clinical trial" @default.
- Q66072163 description "ensayu clínicu" @default.
- Q66072163 description "klinisch onderzoek" @default.
- Q66072163 description "клінічне випробування" @default.
- Q66072163 name "A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer" @default.
- Q66072163 name "A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab" @default.
- Q66072163 type Item @default.
- Q66072163 label "A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer" @default.
- Q66072163 label "A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab" @default.
- Q66072163 prefLabel "A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab (LY3012207) in Participants With Metastatic Pancreatic Cancer" @default.
- Q66072163 prefLabel "A Study of Nab-Paclitaxel and Gemcitabine With or Without Olaratumab" @default.
- Q66072163 P1132 Q66072163-B04503D4-48A0-4246-8F88-87EB03FDD38F @default.
- Q66072163 P1476 Q66072163-4FE0FBA4-7395-4A35-BA08-B24FA2DE7EF4 @default.
- Q66072163 P17 Q66072163-3A236179-5160-49F9-BE30-7972B5A2DD77 @default.
- Q66072163 P17 Q66072163-6373B14F-768C-4019-8BA9-602B1A2C7FD5 @default.
- Q66072163 P17 Q66072163-6828FA10-1B68-4C6E-BA92-497B4DBD0AF3 @default.
- Q66072163 P17 Q66072163-BDB24817-34E9-466C-AD3F-BAF6E6401994 @default.
- Q66072163 P2899 Q66072163-769CC84E-A29A-4B0B-AED2-3BAFD92058ED @default.
- Q66072163 P3098 Q66072163-11C7AB74-ADB3-46CF-AFEA-EB10AA95CC02 @default.
- Q66072163 P31 Q66072163-C901DA9F-D22E-42CD-95EB-69A5E271928B @default.
- Q66072163 P4844 Q66072163-32575D5A-B610-4B75-B1A4-848C1691D6E6 @default.
- Q66072163 P4844 Q66072163-A5C11D0A-FCA8-4A5C-A356-3B12D0C8E7ED @default.
- Q66072163 P580 Q66072163-5D7254A5-9898-449E-B480-FF58ED6E6AEA @default.
- Q66072163 P582 Q66072163-F617180B-5AE6-4196-8219-3EFCBD3B57E2 @default.
- Q66072163 P6099 Q66072163-CD2D6651-9DDF-482B-A628-B5765A2293E9 @default.
- Q66072163 P6099 Q66072163-D791AFCB-1C2C-4596-94CF-ECC2C316C47B @default.
- Q66072163 P6153 Q66072163-159FAB3D-E902-4A00-9CAD-6C09622A32B1 @default.
- Q66072163 P6153 Q66072163-423D7922-86C1-4C18-B1F0-1CFA4CC1836E @default.
- Q66072163 P6153 Q66072163-559724C1-54F9-4912-BABD-786BC0991075 @default.
- Q66072163 P6153 Q66072163-B23D9305-C90C-4D22-A84B-CB34FDFFF5B9 @default.
- Q66072163 P6153 Q66072163-C9761035-95C7-480D-900E-DDEF89406E2D @default.
- Q66072163 P6153 Q66072163-D4925587-A211-4B4C-8CEC-4050007C96BB @default.
- Q66072163 P6153 Q66072163-DFB870DD-492D-4C80-9636-0FC1ABCC5669 @default.
- Q66072163 P6153 Q66072163-F482B1F4-381D-4619-A410-4320A4628A8B @default.
- Q66072163 P8363 Q66072163-48EF1941-76D6-4EB8-8242-040A5CCBBD94 @default.
- Q66072163 P1132 "+186" @default.
- Q66072163 P1476 "A Phase 1b (Open-Label) / Phase 2 (Randomized, Double-Blinded) Study Evaluating Nab-Paclitaxel and Gemcitabine With or Without Olaratumab in the Treatment of First-Line Metastatic Pancreatic Cancer" @default.
- Q66072163 P17 Q183 @default.
- Q66072163 P17 Q29 @default.
- Q66072163 P17 Q30 @default.
- Q66072163 P17 Q38 @default.
- Q66072163 P2899 "+18" @default.
- Q66072163 P3098 "NCT03086369" @default.
- Q66072163 P31 Q30612 @default.
- Q66072163 P4844 Q423762 @default.
- Q66072163 P4844 Q7083108 @default.
- Q66072163 P580 "2017-06-22T00:00:00Z" @default.
- Q66072163 P582 "2020-10-17T00:00:00Z" @default.
- Q66072163 P6099 Q42824440 @default.
- Q66072163 P6099 Q5452194 @default.
- Q66072163 P6153 Q2471216 @default.
- Q66072163 P6153 Q30269604 @default.
- Q66072163 P6153 Q30286943 @default.
- Q66072163 P6153 Q30288563 @default.
- Q66072163 P6153 Q499451 @default.
- Q66072163 P6153 Q6806451 @default.
- Q66072163 P6153 Q7370121 @default.
- Q66072163 P6153 Q7914455 @default.
- Q66072163 P8363 Q78089383 @default.